Biocon Q3 Net Profit Soars 5-Fold to Rs 144 Cr, Driven by Generics & Biosimilars

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Biocon Q3 Net Profit Soars 5-Fold to Rs 144 Cr, Driven by Generics & Biosimilars

Representational image (Image: News18)

N

News18•12-02-2026, 21:45

Biocon Q3 Net Profit Soars 5-Fold to Rs 144 Cr, Driven by Generics & Biosimilars

•Biocon reported a consolidated net profit of Rs 144 crore for Q3 FY25, a five-fold increase from Rs 25 crore in the same quarter last year.
•The significant profit surge was primarily fueled by strong performance in its generics and biosimilar business verticals.
•Revenue for the quarter rose to Rs 4,173 crore, up from Rs 3,821 crore in the year-ago period.
•The board approved the acquisition of the remaining 2% of Biocon Biologics Ltd's equity from employees via preferential allotment of shares.
•Strategic steps, including two QIPs raising USD 1 billion and settlement of debt obligations, have strengthened the company's financial position.

Read Full Article on News18 in English

✦

More like this

✦

More like this

Biocon Q3 Profit Multiplies, Revenue Up 9%, But Misses Market Expectations

Biocon Q3 Profit Multiplies, Revenue Up 9%, But Misses Market Expectations

At previous close, the Sensex was up 266.47 points (0.32 percent) at 83,580.4, and the Nifty was up 50.90 points (0.20 percent) at 25,693.7

Biocon Shares Jump 1.25% Amid High Volumes on Nifty Midcap 150

With the third quarter earnings season drawing to a close, there will be a beeline of companies reporting their quarterly results in the upcoming week. A combination of Nifty 50 companies, F&O stocks, and new listings as well, will be part of the list for the week. Here's a look at some of the major earnings that you should have your eyes on:

Biocon Biologics Targets FY27 Growth with New Approvals, GLP-1 Pipeline

Tuesday, November 11, 2025 | Aavas Financiers, Atlanta Electricals, Atul Auto, Awfis Space Solutions, Bajaj Finserv, Balrampur Chini, Bharat Forge, Bikaji, Biocon, BLS International, Bosch, Borosil Renewables, Ciegall India, Cera Sanitaryware, CONCOR, Cosmo First, Dhampur Sugar, Ecos Mobility, Edelweiss, EID Parry, Emcure Pharma, EPL, ESAF SFB, Finolex Cables, Fortis Healthcare, GMR Power, Godrej Industries, Gokaldas Exports, GSFC, GSPL, Hindustan Copper, HT Media, Indo Count, IFCI, IOL Chemicals, JB Chemicals, Jupiter Wagons, Kolte Patil, Laxmi Dental, Manba Finance, MOIL, One Source, Orchid Pharma, Parag Milk, PC Jewellers, Rategain, RITES, RVNL, Subex, Surya Roshni, Suven Pharma, Tata Power, Texmaco Rail, Thermax, Torrent Power, TransRail Lighting, TVS Srichakra, Yatra Online, Zaggle,

Biocon Q3: Revenue Up 9%, Misses Estimates; Exceptional Loss Hits Profit

Representational image (Image: News18)

Captain Polyplast Q3 Profit Jumps 41% to Rs 9.47 Cr, Driven by Solar Pumps

Representational image (Image: News18)

Grasim Q3 Profit Jumps 28.7% to Rs 2,233 Cr, Revenue Up 25%